Amwell makes grant to new employees under inducement plan

(NYSE:AMWL) Amwell announced that on November 6, 2026, it granted restricted stock units (RSUs) covering an aggregate of 5,761 shares of its Class A common stock to two new employees. These RSU grants were provided as a material inducement to the employees’ employment with Amwell. The vesting schedule for the RSUs stipulates that 25% of the RSUs will vest upon the first anniversary of the grant date, referred to as the Initial Vesting Date. The remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter, beginning on the first calendar day of the month following the date that is three months after the Initial Vesting Date, over a period of three years, until fully vested. The grants were approved by the Compensation Committee of Amwell’s Board of Directors. These grants were made pursuant to Amwell’s Inducement Plan. The grants relied on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Amwell issued this press release in accordance with Rule 303A.08. The RSUs are subject to the applicable employee’s continued employment through each vesting date. The total number of shares covered by these inducement grants is 5,761. The grants are specifically for two new employees joining Amwell. The vesting structure is designed to incentivize retention over a four-year period. The approval and issuance of these RSUs were conducted in compliance with NYSE rules and Amwell’s internal governance procedures.

(NYSE: AMWL) Amwell announced that on August 7, Amwell made grants of RSUs covering an aggregate of 6,679 shares of its Class A common stock to two new non-executive employees. The grants were offered as material inducement to the employees’ entry into employment with Amwell. 25% of the RSUs will vest on the first anniversary of the grant date, referred to as the “Initial Vesting Date”. The remaining 75% will vest in substantially equal quarterly increments thereafter, subject to rounding for whole shares. The RSUs will vest in full on the first day of the calendar month following the 48-month anniversary of the grant date. The vesting schedule is contingent upon each employee’s continued employment through the applicable vesting date.

Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale

Amwell (NYSE: AMWL) announced results from an independently led, National Institute of Mental Health-funded randomized trial published in Nature Human Behaviour, examining SilverCloud® by Amwell®, the company's digital behavioral health solution. The study was conducted across 26 U.S. colleges and universities and included 6,205 students at clinical or high-risk levels for anxiety, depression, and/or eating disorders. Researchers screened nearly 40,000 students and found that individuals offered SilverCloud were over twice as likely to engage, with 74.4% participation compared to 30.2% with traditional behavioral health solutions. The study reported a 4.3% lower prevalence of any mental disorder at six weeks, 4.9% lower at six months, and 3.8% lower at two years for those receiving digital behavioral healthcare. The findings suggest meaningful potential economic value, with up to approximately $1.18 million in avoided mental health–related costs within the study sample. The results support digital mental health programs as part of a broader care strategy for higher education institutions, health plans, and other organizations. The announcement highlights the scalability and effectiveness of Amwell's platform and its impact on participation and long-term outcomes.

Amwell® Announces Results for First Quarter 2026

Amwell (NYSE: AMWL) announced its financial results for the first quarter ended March 31, 2026. The company will host a conference call to discuss these results at 5 p.m. ET, with a live audio webcast available. A replay of the webcast will be accessible for approximately 90 days. Amwell provides a comprehensive SaaS-based software platform for technology-enabled healthcare, serving millions of patients and major healthcare organizations worldwide. The first quarter earnings report is available at investors.amwell.com.